1 Min Read
Nov 7 (Reuters) - Flexion Therapeutics Inc -
* Flexion Therapeutics reports third quarter 2016 financial results
* Qtrly basic and diluted net loss per share $0.65 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.